Cargando…

Proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: A review

Atherosclerotic cerebrovascular disease is one of the major causes of death in China, with associated serious risk of disability and burden on society and families. Therefore, the development of active and effective therapeutic drugs for this disease is of great significance. Proanthocyanidins are a...

Descripción completa

Detalles Bibliográficos
Autor principal: Huang, Pan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134127/
https://www.ncbi.nlm.nih.gov/pubmed/37096349
http://dx.doi.org/10.1177/03000605231167314
_version_ 1785031691527520256
author Huang, Pan
author_facet Huang, Pan
author_sort Huang, Pan
collection PubMed
description Atherosclerotic cerebrovascular disease is one of the major causes of death in China, with associated serious risk of disability and burden on society and families. Therefore, the development of active and effective therapeutic drugs for this disease is of great significance. Proanthocyanidins are a class of naturally occurring active substances, rich in hydroxyl groups and from a wide range of sources. Studies have suggested that they have a strong potential for anti-atherosclerosis activity. In this paper, we review published evidence regarding anti-atherosclerotic effects of proanthocyanidins in different atherosclerotic research models.
format Online
Article
Text
id pubmed-10134127
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-101341272023-04-28 Proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: A review Huang, Pan J Int Med Res Review Atherosclerotic cerebrovascular disease is one of the major causes of death in China, with associated serious risk of disability and burden on society and families. Therefore, the development of active and effective therapeutic drugs for this disease is of great significance. Proanthocyanidins are a class of naturally occurring active substances, rich in hydroxyl groups and from a wide range of sources. Studies have suggested that they have a strong potential for anti-atherosclerosis activity. In this paper, we review published evidence regarding anti-atherosclerotic effects of proanthocyanidins in different atherosclerotic research models. SAGE Publications 2023-04-25 /pmc/articles/PMC10134127/ /pubmed/37096349 http://dx.doi.org/10.1177/03000605231167314 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Huang, Pan
Proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: A review
title Proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: A review
title_full Proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: A review
title_fullStr Proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: A review
title_full_unstemmed Proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: A review
title_short Proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: A review
title_sort proanthocyanidins may be potential therapeutic agents for the treatment of carotid atherosclerosis: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134127/
https://www.ncbi.nlm.nih.gov/pubmed/37096349
http://dx.doi.org/10.1177/03000605231167314
work_keys_str_mv AT huangpan proanthocyanidinsmaybepotentialtherapeuticagentsforthetreatmentofcarotidatherosclerosisareview